Paolo Malvezzi

9PUBLICATIONS
24CO-AUTHORS
PodiatryMajor global burdens of diseaseHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 24, 2025
Life beyond antibodies: quality of life after desensitization in kidney transplantation.

Patrice Zoehinga, Thomas Jouve, Eloi Chevallier

|Oct 18, 2024
Unraveling complexity: morbidity factors in elderly kidney transplant recipients.

Alexandra Gineste, Paolo Malvezzi, Thomas Jouve

|Jun 27, 2024
Calcium-Free Dialysate Hemodialysis: A Simplified Approach.

Alexandra Corbu, Florian Terrec, Paolo Malvezzi

|Mar 28, 2024
Is There a Place for Apheresis in the Management of Idiopathic Membranous Nephropathy? A Report of Three Cases and Literature Review.

Hamza Naciri Bennani, Augustin Twite Banza, Diane Giovannini

|Dec 23, 2023
Adverse Drug Events after Kidney Transplantation.

Lionel Rostaing, Thomas Jouve, Florian Terrec

|Apr 13, 2020
An extension of the RITUX-ERAH study, multicenter randomized clinical trial comparing rituximab to placebo in acute antibody-mediated rejection after renal transplantation.

Elodie Bailly, Simon Ville, Gilles Blancho

Pageof 2